Year |
Citation |
Score |
2023 |
Grover P, Nunez-Cruz S, Leferovich J, Wentz T, Bagchi A, Milone MC, Greene MI. F77 antigen is a promising target for adoptive T cell therapy of prostate cancer. Biochemical and Biophysical Research Communications. 680: 51-60. PMID 37717341 DOI: 10.1016/j.bbrc.2023.09.018 |
0.456 |
|
2017 |
Bagchi A, Haidar JN, Eastman SW, Vieth M, Topper M, Iacolina MD, Walker JM, Forest A, Shen Y, Novosiadly RD, Ferguson KM. Molecular basis for necitumumab inhibition of EGFR variants associated with acquired cetuximab resistance. Molecular Cancer Therapeutics. PMID 29158469 DOI: 10.1158/1535-7163.Mct-17-0575 |
0.665 |
|
2015 |
Ganetzky R, Finn E, Bagchi A, Zollo O, Conlin L, Deardorff M, Harr M, Simpson MA, McGrath JA, Zackai E, Lemmon MA, Sondheimer N. EGFR mutations cause a lethal syndrome of epithelial dysfunction with progeroid features. Molecular Genetics & Genomic Medicine. 3: 452-8. PMID 26436111 DOI: 10.1002/Mgg3.156 |
0.561 |
|
2014 |
Bessman NJ, Bagchi A, Ferguson KM, Lemmon MA. Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor. Cell Reports. 9: 1306-17. PMID 25453753 DOI: 10.1016/J.Celrep.2014.10.010 |
0.685 |
|
2014 |
Bagchi A, Bessman NJ, Wu NZ, Raines L, Kan Z, Hu W, Englander SW, Leahy DJ, Lemmon MA, Ferguson KM. Allosteric Regulation of the Epidermal Growth Factor Receptor Biophysical Journal. 106: 105a. DOI: 10.1016/J.Bpj.2013.11.650 |
0.682 |
|
2013 |
Schmitz KR, Bagchi A, Roovers RC, van Bergen en Henegouwen PM, Ferguson KM. Structural evaluation of EGFR inhibition mechanisms for nanobodies/VHH domains. Structure (London, England : 1993). 21: 1214-24. PMID 23791944 DOI: 10.1016/J.Str.2013.05.008 |
0.531 |
|
Show low-probability matches. |